AI-native pharma disruptors like Palantir, Tempus, and Recursion are reshaping medicine. But ETFs still favor old-school giants.

Lear Corp (LEA) reports $6 billion in revenue and strategic partnerships, while navigating macroeconomic uncertainties and ...

Palantir Technologies Inc.'s AIP is transforming enterprise prospects and driving a $1B run rate. Click to read more on PLTR ...

Fred Alger Management, an investment management company, released its “Alger Mid Cap Focus Fund” second-quarter 2025 investor ...

Discover how Palantir Technologies Inc.'s strong AI adoption and DoD collaboration drive growth. Click for my PLTR earnings ...

Mizuho set a discounted price target on PLTR stock, but seems optimistic ahead of the company's August earnings report.

It has delivered shareholders incredible performance, but everyone wants ... so the real projected Q2 growth rate is likely somewhat higher than this figure. However, Palantir's stock price has risen ...

Palantir Nears The Tough $30 Barrier As Investors Watch Q2 Earnings Amid Fluctuating Stock Performance And Heightened Expectations ...

Palantir Technologies (PLTR) will release its fiscal Q2 financials on August 5. Analysts expect to report earnings of $0.08 per share, up 40% from the prior-year quarter. Meanwhile, analysts ...

Add Palantir Technologies (PLTR) to the long list of stocks that has surged amid the AI-driven momentum. The stock has gone on an impressive run, skyrocketing 122% in six months on investors ...